These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 17952838)
41. Recent developments in the biochemistry of chromium(III). Vincent JB Biol Trace Elem Res; 2004; 99(1-3):1-16. PubMed ID: 15235137 [TBL] [Abstract][Full Text] [Related]
42. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782 [TBL] [Abstract][Full Text] [Related]
43. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Staels B; Maes M; Zambon A Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776 [TBL] [Abstract][Full Text] [Related]
44. Recent advances in the clinical and biochemical effects of chromium deficiency. Anderson RA Prog Clin Biol Res; 1993; 380():221-34. PubMed ID: 8456128 [TBL] [Abstract][Full Text] [Related]
45. Dietary carbohydrate: relationship to cardiovascular disease and disorders of carbohydrate metabolism. Mann J Eur J Clin Nutr; 2007 Dec; 61 Suppl 1():S100-11. PubMed ID: 17992181 [TBL] [Abstract][Full Text] [Related]
47. Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study. Li D; Xu T; Takase H; Tokimitsu I; Zhang P; Wang Q; Yu X; Zhang A Clin Nutr; 2008 Apr; 27(2):203-11. PubMed ID: 18314230 [TBL] [Abstract][Full Text] [Related]
48. Metabolic syndrome: at the crossroads of cardiorenal risk. Natali A; Pucci G; Boldrini B; Schillaci G J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816 [TBL] [Abstract][Full Text] [Related]
49. Chromium deficiency and cardiovascular risk. Simonoff M Cardiovasc Res; 1984 Oct; 18(10):591-6. PubMed ID: 6386156 [TBL] [Abstract][Full Text] [Related]
50. Chromium: celebrating 50 years as an essential element? Vincent JB Dalton Trans; 2010 Apr; 39(16):3787-94. PubMed ID: 20372701 [TBL] [Abstract][Full Text] [Related]
51. The role of galanin in metabolic disorders leading to type 2 diabetes mellitus. Legakis IN Drug News Perspect; 2005 Apr; 18(3):173-7. PubMed ID: 15915218 [TBL] [Abstract][Full Text] [Related]
52. Diet and inflammation: a link to metabolic and cardiovascular diseases. Esposito K; Giugliano D Eur Heart J; 2006 Jan; 27(1):15-20. PubMed ID: 16219650 [TBL] [Abstract][Full Text] [Related]
53. Chromium update: examining recent literature 1997-1998. Preuss HG; Anderson RA Curr Opin Clin Nutr Metab Care; 1998 Nov; 1(6):509-12. PubMed ID: 10565402 [TBL] [Abstract][Full Text] [Related]
54. Nutritional factors influencing the glucose/insulin system: chromium. Anderson RA J Am Coll Nutr; 1997 Oct; 16(5):404-10. PubMed ID: 9322187 [TBL] [Abstract][Full Text] [Related]
55. [Trace elements: zinc, copper, selenium, chromium. Consequences of a deficiency, of excessive trace elements, and value of systematic supplementation]. Favier M; Hininger I J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):109-14. PubMed ID: 9471439 [No Abstract] [Full Text] [Related]
56. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Barbagallo M; Dominguez LJ; Resnick LM Am J Ther; 2007; 14(4):375-85. PubMed ID: 17667214 [TBL] [Abstract][Full Text] [Related]
58. The need for combined inorganic, biochemical, and nutritional studies of chromium(III). Vincent JB; Love ST Chem Biodivers; 2012 Sep; 9(9):1923-41. PubMed ID: 22976981 [TBL] [Abstract][Full Text] [Related]
59. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Lewicki S; Zdanowski R; Krzyżowska M; Lewicka A; Dębski B; Niemcewicz M; Goniewicz M Ann Agric Environ Med; 2014; 21(2):331-5. PubMed ID: 24959784 [TBL] [Abstract][Full Text] [Related]